Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives are to assess the effectiveness and safety of enteral zinc supplementation versus no intervention or placebo on morbidity, growth, and neurodevelopmental development among preterm infants. Seco...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2017-09, Vol.2017 (9)
Main Authors: Staub, Eveline, Evers, Katrina, Askie, Lisa M
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives are to assess the effectiveness and safety of enteral zinc supplementation versus no intervention or placebo on morbidity, growth, and neurodevelopmental development among preterm infants. Secondary objectives include determining: effects of enteral zinc supplementation on morbidities typically seen in preterm infants: bronchopulmonary dysplasia, retinopathy of prematurity, bacterial sepsis, necrotising enterocolitis, and intraventricular haemorrhage; which infants would profit the most from enteral zinc supplementation (within predefined subgroups: gestational age, birth weight, types of enteral feeds); the optimal dose of zinc supplementation: lower dose versus higher dose; or the optimal duration of zinc supplementation: short‐term versus long‐term.
ISSN:1469-493X
DOI:10.1002/14651858.CD012797